Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome

Main|Search|PHGKB






Last Posted: Apr 19, 2018

---

• Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome  
  K Chang et al, JAMA Onc, Apr 16, 2018
• [<p>Lynch syndrome is a major cause of monogenetic familial colorectal cancer</p>].  
  Walton Bernstedt Sophie et al. Lakartidningen 2018 Apr 115
• [Molecular Targeted Therapies for Hereditary Cancer Syndrome].  
  Shimodaira Hideki et al. Gan to kagaku ryoho. Cancer & chemotherapy 2018 Apr 45(4) 587-592
• Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.  
  Cenin Dayna R et al. Journal of gastroenterology and hepatology 2018 Apr
• Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens.  
  Chapel David B et al. Gynecologic oncology 2018 Apr
• Tracking the Translation of Genomic Discoveries to Population Health Benefits: Connecting the Dots from Investment to Population Health Information
  Yu W et al, CDC Blog Post, Apr 2018

more